Applied DNA Sciences Inc
APDN5.620USD
0.000
收盤 12/24, 13:00（美東）報價延遲15分鐘
5.07M總市值
虧損本益比TTM
關於 Applied DNA Sciences Inc 公司
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc簡介
公司代碼APDN
公司名稱Applied DNA Sciences Inc
上市日期Aug 24, 2001
CEOShorrock (Clay)
員工數量46
證券類型Ordinary Share
年結日Aug 24
公司地址50 Health Sciences Drive
城市STONY BROOK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編11790
電話16312408800
網址https://adnas.com/
公司代碼APDN
上市日期Aug 24, 2001
CEOShorrock (Clay)
Applied DNA Sciences Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
由於公司未披露，未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
股東統計
更新時間: 12月24日 週三
更新時間: 12月24日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
其他
96.04%
持股股東
持股股東
佔比
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
其他
96.04%
股東類型
持股股東
佔比
Individual Investor
2.59%
Investment Advisor/Hedge Fund
0.80%
Bank and Trust
0.10%
Investment Advisor
0.07%
Hedge Fund
0.02%
其他
96.42%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
62
12.01K
1.97%
+3.60K
2025Q3
64
19.08K
7.51%
-74.50K
2025Q2
62
93.59K
3.11%
+68.02K
2025Q1
58
35.01K
5.59%
+11.41K
2024Q4
55
23.97K
30.73%
+2.04K
2024Q3
51
1.16K
3.54%
+725.00
2024Q2
53
1.30K
7.24%
+394.00
2024Q1
46
185.00
329.31%
-6.00
2023Q4
44
114.00
24.92%
-67.00
2023Q3
47
182.00
32.27%
+23.00
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
公告日期
類型
比率
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
常見問題
Applied DNA Sciences Inc的前五大股東是誰？
Applied DNA Sciences Inc的前五大股東如下：
Jantzen (Beth M)持有股份：3.00佔總股份比例：0.00%。
Shorrock (Clay)持有股份：4.00佔總股份比例：0.00%。
UBS Switzerland AG持有股份：493.00佔總股份比例：0.04%。
Jantzen (Beth M)持有股份：3.00佔總股份比例：0.00%。
Shorrock (Clay)持有股份：4.00佔總股份比例：0.00%。
UBS Switzerland AG持有股份：493.00佔總股份比例：0.04%。
Applied DNA Sciences Inc的前三大股東類型是什麼？
Applied DNA Sciences Inc 的前三大股東類型分別是：
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
有多少機構持有Applied DNA Sciences Inc(APDN)的股份？
截至2025Q4，共有62家機構持有Applied DNA Sciences Inc的股份，合計持有的股份價值約為12.01K，占公司總股份的1.97% 。與2025Q3相比，機構持股有所增加，增幅為-5.54%。
哪個業務部門對Applied DNA Sciences Inc的收入貢獻最大？
在FY2025Q3，Product and authentication services - Large scale DNA production業務部門對Applied DNA Sciences Inc的收入貢獻最大，創收161.00K，占總收入的52.89% 。
